| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 35,673 | 48,719 | 43,961 | 46,745 |
| Marketable securities | 24,130 | NaN | NaN | NaN |
| Accounts receivable and contract assets, net | 63,076 | 82,669 | 85,496 | 93,189 |
| Other receivables | 2,674 | 2,587 | 5,908 | 3,431 |
| Prepaid expenses and other assets | 2,966 | 3,304 | 5,345 | 7,035 |
| Current assets of discontinued operations | 0 | NaN | NaN | NaN |
| Total current assets | 128,519 | 137,279 | 140,710 | 150,400 |
| Property and equipment, net | 1,743 | 2,025 | 2,206 | 2,389 |
| Right-of-use assets under operating leases, net | 4,403 | 4,947 | 5,328 | 4,633 |
| Intangible assets, net | NaN | 5,553 | 7,007 | 8,462 |
| Goodwill | 110,305 | 110,305 | 110,305 | 159,429 |
| Capitalized software development costs, net | 17,779 | 24,214 | 25,595 | 34,415 |
| Other long-term assets, net | 1,160 | 1,318 | 1,656 | 1,406 |
| Noncurrent assets of discontinued operations | 0 | NaN | NaN | NaN |
| Total assets | 263,909 | 285,641 | 292,807 | 361,134 |
| Accounts payable | 2,600 | 3,360 | 3,613 | 1,945 |
| Accrued compensation | 4,572 | 6,105 | 7,295 | 7,244 |
| Accrued expenses | 9,918 | 7,725 | 7,474 | 6,457 |
| Partner share liability | 17,470 | 24,860 | 22,153 | 27,196 |
| Consumer incentive liability | 20,586 | 32,144 | 32,109 | 35,996 |
| Short-term debt | NaN | 0 | 46,070 | 46,009 |
| Deferred revenue and other liabilities | 2,738 | 2,589 | 3,372 | 3,103 |
| Current operating lease liabilities | 1,467 | 1,607 | 1,617 | 1,199 |
| Current contingent consideration | NaN | 0 | 0 | 0 |
| Current liabilities of discontinued operations | 0 | NaN | NaN | NaN |
| Total current liabilities | 59,351 | 78,390 | 123,703 | 129,149 |
| Convertible senior notes, net | NaN | 168,850 | NaN | NaN |
| Other long-term debt | NaN | 40,070 | NaN | NaN |
| Convertible senior notes, net | 169,131 | NaN | 168,570 | 168,289 |
| Long-term deferred revenue | NaN | 52 | NaN | NaN |
| Lines of credit | 35,070 | NaN | NaN | NaN |
| Long-term operating lease liabilities | 4,360 | 4,787 | 5,176 | 4,915 |
| Long-term deferred revenue | NaN | NaN | 62 | 75 |
| Long-term liabilities of discontinued operations | 0 | NaN | NaN | NaN |
| Total liabilities | 267,912 | 292,149 | 297,511 | 302,428 |
| Common stock, 0.0001 par value100,000 shares authorized and 55,071 and 54,514 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 10 | 10 | 10 | 10 |
| Additional paid-in capital | 1,405,063 | 1,399,542 | 1,393,138 | 1,385,465 |
| Accumulated other comprehensive income (loss), net of tax | -532 | -1,996 | -2,038 | -3,628 |
| Accumulated deficit | -1,408,544 | -1,404,064 | -1,395,814 | -1,323,141 |
| Total stockholders deficit | -4,003 | -6,508 | -4,704 | 58,706 |
| Total liabilities and stockholders deficit | 263,909 | 285,641 | 292,807 | 361,134 |
Cardlytics, Inc. (CDLX)
Cardlytics, Inc. (CDLX)